Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study

Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation (SOT). Most PTLD cases are associated with Epstein–Barr virus (EBV) infection. The role of antiviral prophylaxis or rituximab therapy for prevention of PTLD in SOT recipients is controversial....

Descripción completa

Detalles Bibliográficos
Autores principales: Walti, Laura N., Mugglin, Catrina, Sidler, Daniel, Mombelli, Matteo, Manuel, Oriol, Hirsch, Hans H., Khanna, Nina, Mueller, Nicolas, Berger, Christoph, Boggian, Katia, Garzoni, Christian, Neofytos, Dionysios, van Delden, Christian, Hirzel, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359347/
https://www.ncbi.nlm.nih.gov/pubmed/33289340
http://dx.doi.org/10.1111/ajt.16423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359347/
https://www.ncbi.nlm.nih.gov/pubmed/33289340
http://dx.doi.org/10.1111/ajt.16423

Ejemplares similares